OSAKA (Kyodo) The U.S. biotechnology venture MediciNova debuted Tuesday on the Osaka Securities Exchange's Hercules market, becoming the first foreign company to list on the bourse for startups.

MediciNova began trading at 405 yen, up 5 yen from its initial public offering price.